Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma

Archives of Dermatology

Volumn 140, Issue 12, 2004, Pages 1500-1503

  Seishima, Mariko ^a   Oda, Makiko ^a   Oyama, Zuiei ^a   Yoshimura, Tomoaki ^a   Yamazaki, Futoshi ^a   Aoki, Takahiko ^a   Nei, Mariko ^b   Hashimoto, Takashi ^b  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; DESMOGLEIN 1; DESMOGLEIN 3; ENVOPLAKIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PERIPLAKIN;

ADULT; ANTIBODY TITER; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CHROMAFFIN SYSTEM; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR DENDRITIC CELL; FOLLICULAR DENDRITIC CELL SARCOMA; HUMAN; IMMUNOFLUORESCENCE; LUNG EMBOLISM; LUNG MYCOSIS; MOUTH MUCOSA; PARANEOPLASTIC PEMPHIGUS; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PEMPHIGUS VULGARIS; PHENOTYPE; PLASMAPHERESIS; PRIORITY JOURNAL; SARCOMA;

ANTIBODIES; CADHERINS; DENDRITIC CELLS, FOLLICULAR; DESMOGLEIN 1; DESMOGLEIN 3; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; RETROPERITONEAL NEOPLASMS; SARCOMA;

EID: 10344257565     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.12.1500     Document Type: Article

References (20)

1. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990;323:1729-1735.
2. Anhalt GJ. Paraneoplastic pemphigus. In: Advances in Dermatology. Vol 12. Philadelphia, Pa: Mosby-Year Book Inc; 1997:77-97.
3. Anhalt GJ. Paraneoplastic pemphigus: the role of tumours and drugs. Br J Dermatol. 2001;144:1102-1104.
4. Hashimoto T. Immunopathology of paraneoplastic pemphigus. Clin Dermatol. 2001;19:675-682.
5. Kiyokawa C, Rurhberg C, Nie Z, et al. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. J Invest Dermatol. 1998;111:1236-1238.
6. Nagata Y, Karashima T, Watt FM, et al. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the C-terminal homologous domain of periplakin. J Invest Dermatol. 2001;116:556-563.
7. Amagai M, Nishikawa T, Nousari HC, et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 1998;102:775-824.
8. Ohyama M, Amagai M, Hashimoto T, et al. Clinical phenotype and antidesmoglein autoantibody profile in paraneoplastic pemphigus. J Am Acad Dermatol. 2001;44:593-598.
9. Chan JK, Fletcher CD, Nayler SJ, et al. Follicular dendritic cell sarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer. 1997;79:294-313.
10. Fonseca R, Yamakawa M, Nakamura S, et al. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol. 1998;59:161-167.
11. Jaffe ES. Histocytic and dendritic cell neoplasms: introduction. In: Jaffe ES, Harris NC, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:275-277.
12. Weiss LM, Grogan TM, Müller-Hermelink H-K, et al. Follicular dendritic cell sarcoma/tumour. In: Jaffe ES, Harris NC, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:286-288.
13. Amagai M, Komai A, Hashimoto T, et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmoglein 1 and 3 serodiagnosis of pemphigus. Br J Dermatol. 1999;140:351-357.
14. Amagai M, Tsunoda K, Zillikens D, et al. The clinical phenotype of pemphigus is defined by the antidesmoglein autoantibody profile. J Am Acad Dermatol. 1999;40:167-170.
15. Tsuji Y, Kawashima T, Yokota K, et al. Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system. Arch Dermatol. 2002;138:95-96.
16. Bowen GM, Peters NT, Fivenson DP, et al. Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol. 2000;136:652-656.
17. Inaoki M, Kodera M, Fujimoto A, et al. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol. 2001;144:610-613.
18. Chan LS, Vanderlugt CJ, Hashimoto T, et al. Epitope spreading: lessons from autoimmune skin disease. J Invest Dermatol. 1998;110:103-109.
19. Chan LS. Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases. Arch Dermatol. 2000;136:663-664.
20. Lee I-J, Kim S-C, Kim HS, et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor. J Am Acad Dermatol. 1999;40:294-297.